Insulin resistance associated disorders affect hepatitis B surface antigen decline during long-term entecavir treatment in patients with chronic hepatitis B
Insulin resistance associated disorders affect hepatitis B surface antigen decline during long-term entecavir treatment in patients with chronic hepatitis B